Vital wheat gluten: concentrated protein, studied in celiac disease

The strongest evidence about wheat gluten was collected on the people who have to avoid it. Pooling 35 gluten challenge studies in 1409 adults with celiac disease in remission, the randomized trials found abdominal pain in 56 percent (95% CI 45 to 65), bloating in 55 percent and nausea in 41 percent. Doses of 6 g a day or more made it worse. The pooled studies used very different doses and durations, and these numbers describe people with celiac disease rather than people in general. For everyone else this is a protein concentrate. The single USDA record gives 75.16 g of protein per 3.5 oz (100 g), which is 150 percent of the Daily Value, with 39.7 micrograms of selenium and 5.2 mg of iron. There is no entry for this powder in the US survey portion tables, so those figures stay at 3.5 oz (100 g) of dry powder and nothing here turns them into a serving. One record is also all there is, with no second dataset and no sampling spread behind it.

The numbers, per 3.5 oz (100 g)

How much is actually in it

• Vital wheat gluten is 75.16 g protein per 3.5 oz (100 g) in the USDA reference entry, which is 150 percent of the Daily Value, with 39.7 micrograms selenium and 5.2 mg iron. — The single USDA composition record for vital wheat gluten, FDC 168147, group Cereal Grains and Pasta (n = 1 record) Evidence E source
  Protein 75.16 g (150 percent DV), selenium 39.7 ug (72 percent DV), iron 5.2 mg (29 percent DV) per 3.5 oz (100 g)
• US survey data put median protein intake at 81.9 g a day in men and 61.7 g in women, and selenium at 111 and 84.2 micrograms with 6 and 14 percent below the estimated average requirement. — US adults 19 and over, NHANES 2021-2023, one day of recall Evidence E source
  Protein median 81.91 g men and 61.7 g women; selenium median 111 and 84.2 ug, below EAR at ages 31 to 50 in 6 and 14 percent

What a real portion looks like

• Across 27,806 food samples, 11 percent carried more than 20 mg gluten per kg and 0.51 percent more than 200, a level at which a normal 3.5 to 11 oz (100 to 300 g) portion could pass the 10 mg a day safety threshold. — 27,806 food samples from 59 studies in 28 countries, 1993 to 2024, mostly sandwich ELISA R5 (n = 27806 samples) Evidence D source
  3100 samples (11 percent) above 20 mg/kg, 359 (1.3 percent) above 80 mg/kg, 142 (0.51 percent) above 200 mg/kg

What your body absorbs

• The lysine that wheat protein does contain is 90 percent metabolically available in healthy young men, so the limit is how little lysine wheat holds rather than how well it is absorbed. — Five healthy young males under 30 with BMI below 25, repeated measures indicator amino acid oxidation study with seven lysine intake levels (n = 5) Evidence B source
  Metabolic availability of lysine from whole wheat bread 90 percent
• With 23 g of protein per meal in nine middle-aged women, wheat-based incomplete protein matched complete beef protein for 24 hour muscle protein synthesis, though only the complete and complementary meals beat a low-protein breakfast. — Nine healthy women aged 56 plus or minus 4, randomized crossover of three isonitrogenous 23 g protein conditions, plus eight women on a 5 g protein control breakfast (n = 9) Evidence B source
  No differential effect on fractional synthetic rate after breakfast (P = 0.90) or over 24 h (P = 0.38); complete P = 0.030 and complementary P = 0.031 beat the low-protein control, incomplete did not (P = 0.38)

What cooking and storage change

• Fermentation and enzymatic treatment are the mainstream ways to lower wheat protein allergenicity, hexaploid wheat is the most allergenic, and young children are the group most often affected. — Review of the prevalence of wheat-related allergic reactions and of processing methods to reduce allergenicity Evidence D source
  Biological modification preferred over physical or chemical processing; no effective alternative to a gluten-free diet exists as treatment

What it does to your health

• Pooling 35 gluten challenge studies, abdominal pain hit 56 percent of celiac patients in randomized trials, bloating 55 percent and nausea 41 percent, and doses of 6 g a day or more made it worse. — 1409 adults with celiac disease in remission across 48 eligible studies, 35 pooled, 6 randomized and 29 non-randomized (n = 1409) Evidence A source
  Abdominal pain RCT 0.56 (95% CI 0.45 to 0.65), bloating RCT 0.55 (0.38 to 0.71), nausea 0.41 (0.24 to 0.59)

What people believe that the data does not support

• A systematic review of 17 studies found conclusive evidence for the gluten-free casein-free diet in autism still lacking, even though the opioid peptide hypothesis keeps the diet popular. — 17 articles on opioid peptides and the gluten-free casein-free diet in autism spectrum disorder, 1980 to March 2025 (n = 17 studies) Evidence D source
  Preliminary findings called promising, conclusive evidence of efficacy lacking

Who this works differently for

• Vital wheat gluten given as one 6 g dose made 61 percent of 36 treated celiac patients nauseous and 44 percent vomit within about two hours, with interleukin-2 rising in 97 percent of them. — 36 adults with celiac disease on a gluten-free diet, double-blind bolus challenge and sham two weeks apart, symptoms scored daily (n = 36) Evidence B source
  Nausea 61 percent versus 6 percent with sham, vomiting 44 percent versus 0, median onset 1 hour 34 minutes and 1 hour 51 minutes, interleukin-2 up a median 20-fold in 97 percent

What is still unknown

• Across those 48 studies in 1409 people the challenge doses and durations varied so widely, and symptom reporting was so patchy, that the reviewers call for standardized protocols before the burden can be compared. — The published gluten challenge literature in celiac disease up to December 2024 (n = 48 studies) Evidence A source
  Significant heterogeneity, no systematic reporting of all symptom categories, missing individual data

The bottom line

This page has no separate safety section, and the cautions are real, so they sit here. In a double-blind study, 36 adults with celiac disease on a gluten-free diet swallowed a single 6 g bolus of wheat gluten. Nausea hit 61 percent against 6 percent after the sham, 44 percent vomited against none, the median onset was about an hour and a half, and interleukin-2 rose a median twentyfold in 97 percent of them. That was a bolus rather than a meal, with FODMAPs deliberately removed so the symptoms could be attributed to gluten, and it tells you nothing about people without celiac disease. Wheat protein is also a common allergen, most often in young children, and the review that covers it states there is no effective treatment other than avoiding it, with no numbers for how much fermentation or enzyme treatment lowers allergenicity. This powder is that protein concentrated, which makes it the worst case for anyone who reacts to wheat. A survey of 27,806 food samples from 28 countries found 11 percent carrying more than 20 mg of gluten per kg and 0.51 percent above 200 mg. At that top level a 3.5 to 11 oz (100 to 300 g) portion could cross the 10 mg a day threshold used for celiac disease. That is a finding about traces in foods sold as gluten-free, not about seitan, where the gluten is the product. As a protein source, wheat gluten is short on lysine, and the shortage is in the grain rather than in your gut. In five healthy young men, lysine from whole wheat bread was 90 percent metabolically available, so absorption is not the limiting step. In nine healthy women around 56, a breakfast with 23 g of wheat-based incomplete protein matched complete beef protein for muscle protein synthesis over 24 hours (P = 0.38). Only the complete and the complementary meals beat a 5 g low-protein breakfast (P = 0.030 and P = 0.031), and the incomplete one did not (P = 0.38). Nine women, a surrogate marker rather than strength or muscle, and whole wheat bread rather than seitan. Combining sources across a meal is what the complementary arm of that trial did. US adults already take a median 81.9 g of protein a day in men and 61.7 g in women, and this layer holds no estimated average requirement for protein, so how many people fall short is not a question the page can answer. Median selenium intake is 111 micrograms in men and 84.2 in women, with 6 and 14 percent of 31 to 50 year olds below the requirement. Two claims travel further than their evidence. A systematic review of 17 studies on the gluten-free casein-free diet in autism found the opioid peptide hypothesis unproven in people and conclusive evidence of efficacy still lacking, with preliminary findings the authors call promising. And the question most people arrive with, how much of this powder causes which symptom and in whom, has no answer in the literature. The reviewers of 48 challenge studies in 1409 people say the doses, the durations and the symptom reporting vary too much to compare, and they ask for standardized protocols before anyone tries.

Sources

1. vwg-daily-r3-01 · composition dataset
   Vital wheat gluten (FDC 168147, sr_legacy, Cereal Grains and Pasta): protein 75.16 g 150% DV; selenium 39.7 ug 72% DV; iron 5.2 mg 29% DV per 100 g
   USDA FoodData Central, SR Legacy, 2019, FDC 168147 · checked 2026-09-25
2. vwg-daily-r3-02 · national dietary survey
   NHANES 2021-2023, adults 19+: protein median men 81.91 g, women 61.7 g, no EAR in layer; selenium median men 111 ug, women 84.2 ug, below EAR (ages 31-50) men 6% at 45 ug, women 14% at 45 ug
   NHANES 2021-2023, US dietary intake tables · checked 2026-09-25
3. vwg-daily-r3-09 · scoping review
   Of these, 3100 (11 %) had a gluten content exceeding 20 mg/kg, 359 samples (1.3 %) contained >80 mg/kg, and 142 samples (0.51 %) > 200 mg/kg. ... Regular portions (100-300 g) of foods >200 mg/kg could exceed the 10 mg/day safety threshold.
   Clin Nutr ESPEN, 2026 · checked 2026-09-25
4. vwg-daily-r3-06 · randomized isotope trial
   Five healthy young males (≤30 y, BMI <25 kg/m2) were studied in a repeated-measures design using the indicator amino acid oxidation (IAAO) method, with L-[1-13C] phenylalanine as the indicator. ... The MA of lysine from whole wheat bread was 90%. ... Lysine has a high MA but it is still limiting in whole wheat bread due to its low concentration.
   J Nutr, 2025 · checked 2026-09-25
5. vwg-daily-r3-07 · randomized crossover trial
   Meals containing complete, complementary, or incomplete proteins did not differentially influence FSR responses after breakfast (P = 0.90) or 24 h (P = 0.38). At breakfast, the complete (P = 0.030) and complementary (P = 0.031) protein meals, but not the incomplete protein meal (P = 0.38), had greater FSR responses compared with the low-protein control meal.
   J Nutr, 2024 · checked 2026-09-25
6. vwg-daily-r3-08 · narrative review
   Studies reveal that hexaploid wheat exhibits notably higher allergenicity. Early childhood is associated with a higher prevalence rate, although some symptoms may alleviate or disappear with age. ... Among methods to reduce wheat protein allergenicity, biological modification is preferred over physical processing and chemical modification. Fermentation and enzymatic treatment are currently mainstream choices, while gene editing holds the most promise for a definitive solution to WRARs. Unfortunately, no effective alternative to a gluten-free diet currently exists as a treatment measure.
   Crit Rev Food Sci Nutr, 2026 · checked 2026-09-25
7. vwg-daily-r3-04 · meta-analysis of challenge trials
   We identified 48 eligible studies with a total of 1,409 participants of which 35 were included in the meta-analysis (6 RCTs, 29 non-RCTs). The most common symptoms were abdominal pain (RCT 0.56, 95% confidence interval [CI] 0.45-0.65; non-RCT 0.40, 95% CI 0.32-0.49), bloating (RCT 0.55, 95% CI 0.38 to 0.71; non-RCT 0.37, 95% CI 0.28-0.47), and nausea (0.41, 95% CI 0.24-0.59; non-RCT 0.34, 95% CI 0.24-0.46). ... Bloating, fatigue, flatulence, and nausea were significantly more reported in studies administering ≥6 g gluten/d.
   Am J Gastroenterol, 2026 · checked 2026-09-25
8. vwg-daily-r3-10 · systematic review
   Among these, the gluten-free, casein-free (GFCF) diet is one of the most frequently adopted strategies. A leading hypothesis posits that those increased concentrations of opioid peptides such as gluteomorphin and caseomorphin derived from the incomplete digestion of gluten and casein may contribute to the severity of ASD symptoms. ... Although preliminary findings from clinical and laboratory studies are promising, conclusive evidence regarding the efficacy of the GFCF diet remains lacking.
   Metab Brain Dis, 2026 · checked 2026-09-25
9. vwg-daily-r3-03 · randomized crossover challenge trial
   Double-blind, bolus vital wheat gluten (~6-g gluten protein) and sham challenges low in FODMAPs were consumed 2 weeks apart. ... Nausea (6% vs 61%, P < .001; median onset: 1:34 hours) and vomiting (0% vs 44%, P < .001; 1:51 hours) were the only adverse events more common with gluten than sham. ... Interleukin-2 was elevated after gluten in 97% of patients (median fold-change: 20)
   Aliment Pharmacol Ther, 2020 · checked 2026-09-25
10. vwg-daily-r3-05 · meta-analysis of challenge trials
    There was significant heterogeneity across studies, with variable GC doses and durations, no systematic reporting of all symptom categories, and missing individual data for some studies. ... Standardized challenge protocols are needed to advance therapeutic research while minimizing symptom burden.
    Am J Gastroenterol, 2026 · checked 2026-09-25